A novel yeast expression system for the overproduction of quality-controlled membrane proteins  by Griffith, Douglas A et al.
A novel yeast expression system for the overproduction of
quality-controlled membrane proteins
Douglas A. Gri⁄tha;, Christina Delipalaa, Jane Leadshamb, Simon M. Jarvisb,
Dieter Oesterhelta
aMax-Planck-Institute for Biochemistry, Department of Membrane Biochemistry, Am Klopferspitz 18a, 82152 Martinsried, Germany
bSchool of Biosciences, University of Westminster, 115 New Cavendish Street, London W1W 6UW, UK
Received 24 June 2003; revised 30 July 2003; accepted 4 August 2003
First published online 18 September 2003
Edited by Irmgard Sinning
Abstract Saturation of the cell’s protein folding capacity and
accumulation of inactive incompletely folded protein often ac-
companying the overexpression of membrane proteins (MPs)
presents an obstacle to their e⁄cient puri¢cation in a functional
form for structural studies. We present a novel strategy for
optimization of functional MP expression in Saccharomyces
cerevisiae. This approach exploits the unfolded protein response
(UPR) pathway, a stress signaling mechanism that senses the
accumulation of unfolded proteins in the endoplasmic reticulum.
We demonstrate that a high level of UPR induction upon ex-
pression of a MP re£ects impaired functional expression of that
protein. Tuning the expression level of the protein so as to avoid
or minimize UPR induction results in its increased functional
expression. UPR status can therefore serve as a proxy variable
for the extent of impaired expression of a MP that may even be
applicable in the absence of knowledge of the protein’s biolog-
ical function.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The production of properly folded membrane proteins
(MPs) in the quantities required for structure determination
is currently an enormous challenge. This situation re£ects the
limitations of existing systems for the overexpression of MPs
of relatively low abundance [1,2]. Yeast-based expression sys-
tems show the greatest promise for the development of inex-
pensive alternatives to MP expression in Escherichia coli, par-
ticularly for medically important polytopic eukaryotic MPs,
the overwhelming majority of which cannot be functionally
overproduced in bacteria [1,3^5]. They are genetically £exible,
suitable for large-scale fermentation, and unlike E. coli, per-
form some types of eukaryotic post-translational modi¢ca-
tions [1,3]. However, their use has been greatly hampered
because traditional expression protocols employing strong
promoters and/or multicopy vectors often lead to saturation
of the cell’s protein folding capacity and accumulation of in-
active unfolded or misfolded protein in intracellular mem-
branes [6^10]. This situation complicates subsequent puri¢ca-
tion of functional protein as it often necessitates the inclusion
in the puri¢cation scheme of a step based on the biological
activity of the protein, such as ligand a⁄nity chromatogra-
phy. In the emerging ¢eld of MP structural genomics, such an
approach to puri¢cation is untenable for the vast number of
proteins for which functional information is lacking. In addi-
tion, failure to remove those molecules of a MP with non-
native structures from a puri¢ed preparation that is to be used
for 3D crystallization will result in their incorporation into a
growing crystal, thus ‘poisoning’ the growth process, and so
producing small (6 50 Wm), imperfectly ordered crystals with
no or poor di¡raction properties [11].
We set out to develop an improved expression system using
the budding yeast, Saccharomyces cerevisiae, for MPs that
reach their ¢nal cellular destination via the secretory pathway.
Our aim was to exploit the unfolded protein response (UPR)
pathway, a protein quality control mechanism operating in
the endoplasmic reticulum (ER), to optimize the yields of
correctly folded and targeted recombinant MPs. The UPR is
an adaptive cellular mechanism that monitors the folding state
of nascent polypeptides in the lumen of the ER, and during
times of increased secretory and MP protein biosynthesis, ad-
justs the levels of luminal chaperones and folding enzymes
accordingly. Proteins that fail to fold correctly, even after
the folding capacity of the ER has been boosted, are degraded
by pathways that are also regulated by the UPR, speci¢cally,
those targeting proteins to the vacuole and ER-associated
degradation (ERAD) [12^14]. In yeast, activation of gene ex-
pression by the UPR (Fig. 1) is dependent on a transmem-
brane kinase, Ire1p, which resides in the ER. In the resting
state, Ire1p is maintained in an inactive, monomeric form by
binding to the ER luminal chaperone Kar2p, the yeast BiP
homologue. Elevated levels of unfolded or misfolded proteins
in the ER compete with Ire1p for binding to Kar2p freeing
some Ire1p which dimerizes, undergoes trans-autophosphory-
lation, and initiates downstream signaling to the transcription-
al apparatus [15]. Here we present a novel yeast expression
system that combines tunable MP expression with an in vivo
protein folding assay based on the UPR.
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2. Materials and methods
2.1. Plasmid construction
All constructs were con¢rmed by dye terminator sequencing. Multi-
copy vectors for the expression of functional C-terminally tagged
Ste2p and P2 (encoded by the TeAT1 gene, GenBank accession num-
ber AJ278417) were constructed using a modi¢ed version of plasmid
pYES260 [16] (obtained from EUROSCARF, Frankfurt, Germany).
A DNA fragment containing a SmaI site and encoding both FLAG
and His6 tags was ligated into HindIII/NotI-digested pYES260. The
XhoI site in the vector was then removed by XhoI digestion, T4 poly-
merase ¢ll-in and religation to yield pYES2-FT.HT. A variant of
pYES2-FT.HT was constructed by removal of a 484-bp PstI fragment
containing the entire URA3 gene promoter (pYES2-URA3-d-FT.HT).
The genes were cloned into pYES2-FT.HT by in vivo homologous
recombination in yeast [17]. The STE2 and TeAT1 genes were ampli-
¢ed by polymerase chain reaction (PCR) from yeast genomic DNA
(from strain S288C; Research Genetics, Huntsville, AL, USA) and
plasmid pJL19, respectively. The PCR primers added 30 bp of se-
quence to the ends of the genes that are homologous to those £anking
the SmaI site at the desired point of insertion between the GAL1
promoter and the a⁄nity tags. The STE2 gene was cloned into
pYES2-URA3-d-FT.HT in an identical manner (URA3-d-STE2p).
The tunable N integration vector for P2 was constructed by excising
the P2 expression cassette from the multicopy plasmid as a MluI/SpeI
fragment, and blunt-end ligation into the blunted SacI-digested pITy3
vector [18].
The UPR reporter plasmids were constructed from the pJS401 vec-
tor [19], which contains a transcriptionally silent ICL1 promoter in
front of lacZ, by integrating a fragment containing the UPR element
(UPRE) into the BglII/SalI site in the promoter. A variant of this
construct carrying alternative selection markers was generated by in-
troducing the TRP1 gene at a unique HindIII site, and then replacing
the URA3 gene with the Tn903 kanr marker from pITy3 by PCR-
directed recombination.
2.2. Yeast transformation, growth and galactose induction
Transformation of strain BJ5464 with multicopy vectors was done
by a yeast colony lithium acetate technique [20]. Expression cultures
were grown in medium containing 0.67% yeast nitrogen base (YNB),
2% casamino acids, 4% ra⁄nose, and bu¡ered at pH 6.0 with 50 mM
sodium phosphate. The N strains were generated by transformation of
BJ5464[cir-0] (cured of the 2-Wm plasmid as described [21]) harboring
pMEGA2-vURA3 [22] and a UPRE-lacZ plasmid with 5 Wg of XhoI-
digested P2 N vector or pITy-3 (as control) using a high-e⁄ciency
lithium acetate method [23]. Transformants were selected on plates
containing 5 mg/ml G418. For expression studies, N strains were
grown in 1% yeast extract, 2% bacto-peptone and 4% ra⁄nose at
30‡C and induced with 2% galactose at an OD600 of 1^2.
2.3. Southern blotting
P2 gene copy number was determined by Southern analysis as de-
scribed [18]. Probe synthesis, hybridization and detection were per-
formed with digoxigenin (DIG) system reagents according to the DIG
application manual (Roche Applied Science, Mannheim, Germany).
Exposed ¢lms, for which responses were in the linear range, were
scanned using an Agfa Snapscan 600 £atbed scanner and densitom-
etry performed with Scion Image Software (Scion Corporation, Re-
lease Beta 4.0.2). Copy number determinations were performed in
triplicate.
2.4. Adenosine and histidine transport assays
Cells were harvested, washed three times with a medium containing
0.67% YNB and 2% galactose (MMG), and resuspended in the same
medium to an OD600 of 6 and 40 for adenosine and histidine transport
assays, respectively. Aliquots of cells (50 Wl) were added to the same
volume of MMG containing 2 WM [3H]adenosine (NEN Life Science,
Boston, MA, USA) or 1.2 mM L-[3H]histidine (Amersham Pharmacia
Biotech), and incubated for 10 and 2 min, respectively, at 22^24‡C.
Control experiments showed that the time intervals used were well
within the initial linear phase of substrate accumulation curves and
thus approximate initial rates of transport. In£ux was terminated by
the addition of 1 ml of ice-cold MMG (containing 1 mM adenosine in
adenosine uptake assay) and ¢ltration of the cell suspension under
vacuum through 0.45-Wm Whatman GF/F ¢lters. The ¢lters were
washed once with 10 ml of the same ice-cold medium and the retained
radioactivity was measured by liquid scintillation counting.
2.5. Preparation of membranes and total cell extracts
Total and plasma membranes were isolated as described [24,25].
Protein concentrations were determined by the Pierce BCA microas-
say (Perbio Science, Bonn, Germany) in the presence of 0.5% sodium
dodecyl sulfate (SDS) using bovine serum albumin as standard. Total
cell protein extracts were prepared as described [26].
2.6. SDS^polyacrylamide gel electrophoresis and immunoblotting
Expressed proteins were analyzed by electrophoresis through 8%
Tricine^SDS polyacrylamide gels [27]. Ste2p and P2 were detected
by Western blotting with a murine monoclonal anti-Penta-His anti-
body (Qiagen, Hilden, Germany) and the Western-Star1 chemilumi-
nescent immunoblot detection kit (Applied Biosystems, Bedford, MA,
USA). Immunodetection of the plasma membrane Hþ-ATPase was
done with a rabbit polyclonal anti-yeast Hþ-ATPase antibody. Densi-
tometry was performed on data collected within the linear response
range for protein concentration and ¢lm exposure.
2.7. UPR induction
Assay of L-galactosidase (L-gal) was carried out as described [28]
and the activity normalized to the protein concentration determined
using the Bio-Rad protein assay (Bio-Rad Laboratories, Munich,
Germany).
3. Results
3.1. Expression of trypanosomal adenosine transporter
activates UPR
To test how readily achievable UPR induction is upon the
functional expression of plasma MPs in S. cerevisiae, we ex-
pressed the S. cerevisiae K-factor receptor (Ste2p) and the
Trypanosoma equiperdum P2 Hþ/adenosine cotransporter
from a multicopy 2W-based vector under the control of the
GAL1 promoter in cells carrying a sensitive reporter of UPR
activation. The reporter construct consists of the L-gal gene
(lacZ) driven by a single UPRE from the KAR2 promoter
Fig. 1. The UPR signaling pathway in S. cerevisiae. Increased levels
of unfolded/misfolded proteins in the ER decrease the levels of free
Kar2p by binding to it. The occupancy of Kar2p bound to Ire1p is
reduced and promotes Ire1p dimerization. Ire1p trans-autophosphor-
ylates activating its nuclease domain. Through the action of Ire1p
and tRNA ligase (Rlg1p), the constitutively expressed transcript for
Hac1p (HAC1u), the UPR-speci¢c transcription factor, is processed
by removing its intron, leading to Hac1p synthesis. Hac1p translo-
cates to the nucleus, binds the UPR element (UPRE) of target
genes, and induces their expression. Red arrow indicates processes
occurring when UPR is o¡ and green arrows when UPR is on.
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(UPRE [29]; Fig. 1) on a multicopy vector. Fig. 2A shows
that Ste2p expression had little e¡ect on L-gal activity. A
further V2-fold increase in Ste2p expression achieved by us-
ing a version of the vector in which the promoter of the URA3
selection marker was removed (URA3-d-STE2p) still failed to
elicit a UPR (Fig. 2A).
In contrast, overexpression of the P2 transporter resulted in
a greater than 70-fold increase in L-gal activity (Fig. 2A),
although it was up to 20-fold less abundant in yeast total
membranes than Ste2p (Fig. 2B). To test whether our inability
to detect UPR induction upon expression of Ste2p might be
due to impaired UPR functioning accompanying its higher
level of expression, we examined the e¡ect of Ste2p and P2
expression on a dithiothreitol (DTT)-induced UPR. DTT dis-
rupts protein folding in the ER by preventing disul¢de bond
formation and is often used to induce the UPR [15]. DTT-
induced responses in cells expressing P2 and Ste2p from the
original 2W vectors were of a similar magnitude suggesting
that the absence of UPR induction upon expression of
Ste2p is unlikely to be due to a compromised UPR (Fig.
2A). Surprisingly, expression of either protein resulted in
DTT-induced responses that were 6 50% of that seen in the
control strain. This e¡ect may result from an increased oxi-
dation of the DTT. Recently it was shown that the prolifer-
ation of ER membranes occurring upon the impaired secre-
tion of a heterologous modi¢ed fungal cutinase resulted in
oxidative stress, and as a consequence, the carbonylation of
cellular proteins [30].
3.2. A novel expression strategy
To determine whether the observed UPR induction upon
expression of the P2 adenosine transporter re£ects its im-
paired functional expression, the expression system depicted
in Fig. 3 was constructed. This system allows sampling of a
range of P2 synthesis levels above and below that at which the
UPR is induced. In order to avoid the occurrence of a tran-
scriptional limit imposed by the low cellular levels of the ga-
lactose-responsive transcriptional switch proteins (Gal4p-
Gal80p-Gal3p) in cells carrying multicopies of the GAL1 pro-
moter, Gal4p, Gal80p and Gal3p were overexpressed from the
pMEGA2-vURA3 plasmid [22]. The P2 expression cassette
from the 2W vector was subcloned into the tunable N integra-
tion vector [18]. This vector carries the bacterial NEO kana-
mycin resistance gene and results in stable integration of mul-
tiple gene copies into the Ty N sequences of S. cerevisiae
chromosomal DNA (Fig. 3). In general, the NEO-conferred
geneticin resistance (G418R) of a transformant increases mo-
notonically with increasing N vector copy number, thus allow-
ing the tuning of gene copy number by varying the geneticin
concentration used for transformant selection [18]. A pro-
tease-de¢cient strain, BJ5464[cir-0], harboring pMEGA2-
vURA3 and a UPRE-lacZ reporter plasmid, was transformed
with the P2 N vector.
3.3. Strong activation of UPR re£ects impaired P2 expression
We determined P2 gene copy number, L-gal activities, initial
rates of [3H]adenosine in£ux into intact cells, and P2 expres-
sion in total cell protein extracts, for eight transformants that
were designated w1, w2, lb1, lb2, lb3, db1, db2, db3
(N strains), and compared these results with those obtained
with the 2W strain (2W-P2) under identical growth conditions
(Fig. 4). P2 gene copy number was determined by Southern
Fig. 2. Expression of P2 transporter activates UPR. A: L-Gal mea-
surements on cells harboring a UPRE-lacZ plasmid and expressing
Ste2p and P2 (C-terminally FLAG-His6-tagged) from multicopy vec-
tors at 48 h galactose induction. For DTT-treated samples, 3 mM
DTT was added with galactose and activity measured after 4 h.
URA3-d-Ste2p denotes a vector with increased copy number due to
poor expression of the URA3 marker [42]. Results expressed relative
to zero galactose induction time values are meansUS.E.M. (n=3^
6). B: An immunoblot representative of two experiments prepared
with total membranes from 4 h galactose-induced cultures. Lane 1,
His6-tagged ladder; lane 2, 20 Wg control; lane 3, 20 Wg P2; lane 4,
1 Wg URA3-d-Ste2p; lane 5, 1 Wg Ste2p. The anti-His6 antibody
used to probe the blot showed no cross-reactivity with proteins in
the control membranes, and speci¢cally labeled P2 which migrated
with an apparent molecular mass of 40 kDa (predicted molecular
mass of 54 kDa including 3-kDa tags) and Ste2p which showed
multiple bands in the range 46^56 kDa as previously reported [43].
Fig. 3. A novel yeast expression system with in vivo protein folding
assay based on the UPR. Boxed black triangles in the tunable N in-
tegration vector represent N sequences which target chromosomal in-
tegration of the vector by homologous recombination to the 150^
200 copies of the Ty N sequence present on yeast chromosomes [18].
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analysis of total yeast DNA. Surprisingly, although the P2
gene was detectable in genomic DNA from strains w1, w2
and lb1, P2 expression in these strains could not be detected
in immunoblots or adenosine uptake experiments (data not
shown). The reason that these strains failed to express P2 is
presently unclear. P2 gene copy numbers in the remaining
strains were 45U 5, 13U 3, 7 U 1, 20U 2, 10U 2 and 12U 1,
for 2W-P2, lb2, lb3, db1, db2 and db3, respectively.
Strikingly, for those strains in which P2 expression could be
detected in immunoblots, cell surface expression of the trans-
porter, as assessed by initial rates of adenosine transport after
4 h of galactose induction, was inversely related to the degree
of UPR induction (Fig. 4A). L-Gal activities were measured
after 48 h of galactose induction to allow accumulation of this
long-lived enzyme (half-life in yeast V20 h [31]), and thus
detection of low levels of UPR activation. The degree of
UPR induction was directly related to the level of P2 protein
expression except in strain 2W-P2 (Fig. 4B). The di¡erence in
P2 protein abundance between strains does not account for
the di¡erences in their transport activity. For instance, the
amount of expressed P2 in cell extracts of 2W-P2, lb2 and
lb3 was similar, although the rate of adenosine transport
was four-fold lower for 2W-P2 than for lb2 and lb3. Although
the abundance of P2 protein does not clearly correlate with P2
gene copy number in the N strains, db1 with the highest copy
number does show the highest P2 expression level. The 2W-P2
strain with anV2-fold higher copy number than db1, surpris-
ingly, showed V3-fold lower P2 levels. These results taken
together suggest that the synthesis of the P2 transporter in
strain 2W-P2 occurs at a rate that overwhelms the ER’s folding
machinery, strongly activating the UPR, and leading to its
increased degradation via the ERAD pathway.
To examine whether increased transport activity in the
N strains was due to improved surface expression of functional
P2 protein, transporter abundance in puri¢ed plasma mem-
branes from lb3 and 2W-P2 was examined (Fig. 5A). Unex-
pectedly, the average improvement in transporter expression
was only 1.3U 0.3-fold (n=4). This modest increase does not
readily explain the V4-fold di¡erence in adenosine transport
activity shown by these strains (Fig. 4A). One explanation for
the discrepancy might be that in 2W-P2, one or more compo-
nents of the quality control apparatus have been saturated
allowing inactive unfolded/misfolded P2 transporters to es-
cape from the ER, as has been suggested to occur upon over-
expression of the vF508 mutant of the cystic ¢brosis trans-
membrane conductance regulator [32].
A remarkable di¡erence between membranes from lb3 and
2W-P2, revealed on inspection of Coomassie-stained gels (data
not shown), is the decreased abundance of a band with an
apparent molecular mass of 100 kDa in lb3 membranes. This
protein was identi¢ed as the plasma membrane Hþ-ATPase in
immunoblots and was V4-fold less abundant in lb3 mem-
branes than in control membranes (Fig. 5B). Its expression
in 2W-P2 was only slightly reduced (V1.2-fold). The Hþ-ATP-
ase generates the electrochemical proton gradient that pro-
vides the driving force for nutrient uptake by Hþ-dependent
cotransporters [33,34]. Reducing Hþ-ATPase expression has
been shown to result in decreased amino acid transport [35].
These results suggest that the driving force for Hþ-coupled
adenosine transport is likely to be reduced in the N strains
compared to 2W-P2 under these conditions, and thus the im-
provement in functional expression of P2 in the N strains, as
assessed by adenosine uptake (Fig. 4A), is probably under-
estimated. Strong support for this conclusion comes from the
observation that initial rates of endogenous Hþ-coupled his-
tidine transport under identical conditions were signi¢cantly
lower in lb3 and db1 compared to 2W-P2 (27U 1, 20U 2 and
69U 3 pmol/107 cells/min, respectively, meansU S.E.M., n=3).
Additional evidence in favor of this interpretation of these
data is provided by experiments examining P2 expression as
a function of the galactose induction time (Fig. 6). The levels
Fig. 4. Strong activation of UPR re£ects impaired P2 expression.
A: Inverse correlation between the initial rates of 1 WM
[3H]adenosine uptake into intact cells (at 4 h induction) and the de-
gree of UPR induction (L-gal activity measured at 48 h induction).
B: Correlation between degree of UPR induction and the level of
P2 protein expression. Expression levels were determined by immu-
noblotting of total cell protein extracts from 4 h galactose-induced
cultures and are expressed relative to that in 2W-P2. Results are
meansUS.E.M. (n=3).
Fig. 5. Comparison of P2 levels in puri¢ed plasma membranes from
2W-P2 and lb3. Five Wg of membranes prepared from 4 h galactose-
induced cultures were analyzed. A: Immunodetection of P2. B: Im-
munoblot probed with anti-yeast Hþ-ATPase antibody. Results are
representative of three independent experiments.
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of P2 protein in plasma membranes from lb3 and db1 at
di¡erent induction times (Fig. 6B) do not readily account
for the observed changes in transport activity (Fig. 6A). An
explanation for this apparent anomaly is suggested by the
unexpected ¢nding that in lb3, expression of the Hþ-ATPase
recovered from its V4-fold reduced level at 4 h to near nor-
mal levels at 16 h (Fig. 6C). Therefore, peak expression of
functional P2 in these strains occurs at around 4 h and ap-
pears to coincide with the lowest levels of Hþ-ATPase expres-
sion. Changes in transport activities thereafter re£ect altera-
tions in both P2 and Hþ-ATPase cell surface abundance.
Strain db1 showed the highest level of P2 expression (Fig.
6B: 3^5% of plasma membrane protein as estimated by com-
parison of the immunoblot signal with that obtained from
known amounts of the 53 kDa His6-tagged protein, Posi-
tope1 (data not shown)) and will be used for future puri¢ca-
tion and crystallization work.
4. Discussion
One of the most vexing problems facing a structural ge-
nomics approach to MPs is the inadequate supply of puri¢ed
properly folded MPs. This problem provided the motivation
for the development of a novel strategy for MP overexpres-
sion in S. cerevisiae that exploits a cellular protein quality
control mechanism, the UPR, to assess the productive folding
of recombinant MPs in vivo. This approach allowed us to
demonstrate that for some plasma MPs, exempli¢ed by the
P2 adenosine transporter, the use of traditional expression
methods employing strong promoters and multicopy vectors
may lead to saturation of the ER’s protein folding apparatus
and their impaired expression. Reducing synthesis rates for
such proteins to a level that better matches the ER’s folding
capacity may result in their improved functional expression,
as found here for the P2 transporter. We have found that two
human G protein-coupled receptors (GPCRs) that are func-
tionally expressed in S. cerevisiae induce the UPR to a similar
extent as the P2 transporter (D.A. Gri⁄th, unpublished re-
sults), suggesting that the functional expression of these pro-
teins may also be improved by our approach. Further experi-
ments are currently under way. Homologous overexpression
of the K-factor receptor did not activate the UPR suggesting
that this protein does not encounter severe problems in the
folding of its ER lumen-exposed domains. We have also
found that the overproduction of several plant solute trans-
porters in S. cerevisiae has little e¡ect on the activity of the
UPR pathway (D.A. Gri⁄th, unpublished results). These re-
sults taken together suggest that the strategy we have devel-
oped may be most applicable to MPs from organisms which
are distantly related in evolutionary terms to S. cerevisiae.
These are exactly the proteins which have proved to be the
most di⁄cult to e⁄ciently express in this yeast [1].
An additional advantage of our approach is that optimiza-
tion of functional expression of a protein occurs in a single
step with the isolation of transformants showing low levels of
UPR induction. This obviates the need to perform time-con-
suming studies on the e¡ects of reduced cultivation temper-
ature and modi¢ed growth media on the protein’s functional
expression.
Previously reported systems for monitoring in vivo folding
of recombinant proteins were developed with E. coli and rely
on a ‘folding reporter’ protein that indicates the extent of
productive folding of fused protein domains [36^38]. Aggre-
gation of target proteins and their incorporation into inclu-
sion bodies was correlated with reduced formation of the
functional reporter proteins. It is unclear whether such an
approach will work in yeasts which have a reduced tendency
for inclusion body formation. These approaches have also
thus far only been used to screen for proteins that fold e⁄-
ciently in E. coli, and not, as has been done in this study, to
optimize the expression of a single variant.
In the present work, we demonstrate for the ¢rst time that a
protein quality control stress response, the UPR, can be ex-
ploited to optimize synthesis rates of a MP so as to better
utilize the intrinsic protein folding capacity of the host cells.
Our system has potential applications in addition to the pro-
vision of native membrane protein samples for structural stud-
ies. For instance, improved cell surface expression of human
GPCRs in S. cerevisiae should facilitate the development of
high-throughput screening assays for novel ligands [39^41].
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